Showing results (381-390 of 392) with videos related to
Sort By:
Pageof 40
Infection and Immunity|August 1, 1997
Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopesY Charoenvit, V Fallarme, W O Rogers, et al.Antimicrobial Agents and Chemotherapy|April 27, 2016
Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis AgentsShayna Sandhaus, Thirunavukkarasu Annamalai, Greg Welmaker, et al.Blood|October 6, 2007
Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cellsSaskia A G M Cillessen, John C Reed, Kate Welsh, et al.Journal of Medicinal Chemistry|October 1, 2021
Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) AntagonistMark D Ericson, Skye R Doering, Courtney M Larson, et al.Journal of Medicinal Chemistry|April 29, 2017
Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa<sup>1</sup>-Arg-(pI)DPhe-Xaa<sup>4</sup>-NH<sub>2</sub>Skye R Doering, Katie T Freeman, Sathya M Schnell, et al.ACS Chemical Biology|May 7, 2019
A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate PhosphorylationRachel M Sammons, Nicole A Perry, Yangmei Li, et al.Cancer Cell|January 30, 2004
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activityAaron D Schimmer, Kate Welsh, Clemencia Pinilla, et al.European Journal of Medicinal Chemistry|January 7, 2015
Synthesis and biological evaluations of novel endomorphin analogues containing α-hydroxy-β-phenylalanine (AHPBA) displaying mixed μ/δ opioid receptor agonist and δ opioid receptor antagonist activitiesMiao Hu, Marc A Giulianotti, Jay P McLaughlin, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 1997
Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and diseaseA Hildesheim, M H Schiffman, T Tsukui, et al.The Lancet. Infectious Diseases|July 13, 2020
The value of antimicrobial peptides in the age of resistanceMaria Magana, Muthuirulan Pushpanathan, Ana L Santos, et al.Pageof 40